Watch KRMD. Know when insiders buy.
One email the day a filing lands. Free.
KRMD
KORU Medical Systems, Inc.
3.15
−0.02 −0.63%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
59
WATCH · insiders 60, shorts 57
Insiders, 90 days
+$101K
net buying · 1 buy, 0 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $145.4MP/E —DIV YIELD —FCF YIELD 0.53%REV TTM $45.1M +22.4%NET INCOME −$1.8MNET CASH $7.8M52W 3.15 – 6.52SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $12M | +18.2% | 65.1% | $627K | $252K | — | 0.01 | $216K | $108K | $108K | Aug 5 |
| Q1 2026 · Mar 31 | $11.8M | +22.1% | 61.5% | −$865K | −$807K | — | -0.02 | $15K | $46K | −$32K | Aug 5 |
| Q4 2025 · Dec 31derived | $10.9M | +23.3% | 62.6% | −$547K | −$487K | — | -0.11 | $1.1M | $408K | $687K | Mar 12 |
| Q3 2025 · Sep 30 | $10.4M | +27.2% | 60.2% | −$868K | −$778K | — | 0.02 | $65K | $52K | $13K | Nov 12 |
| Q2 2025 · Jun 30 | $10.2M | +20.9% | 63.5% | −$313K | −$207K | — | 0.00 | −$460K | $29K | −$489K | Aug 5 |
| Q1 2025 · Mar 31 | $9.6M | +17.5% | 62.8% | −$1.2M | −$1.2M | — | -0.03 | −$237K | $443K | −$681K | Aug 5 |
| Q4 2024 · Dec 31derived | $8.8M | +23.0% | 62.9% | −$1.6M | −$1.6M | — | -0.23 | $940K | −$44K | $983K | Mar 12 |
| Q3 2024 · Sep 30 | $8.2M | +16.8% | 63.4% | −$1.7M | −$1.6M | — | 0.03 | −$924K | $1.1M | −$2M | Nov 12 |
| Q2 2024 · Jun 30 | $8.4M | — | 65.0% | −$1.2M | −$989K | — | 0.02 | $11K | $124K | −$113K | Nov 12 |
| Q1 2024 · Mar 31 | $8.2M | — | 62.3% | −$2M | −$1.9M | — | 0.04 | −$347K | $133K | −$480K | Nov 12 |
| Q4 2023 · Dec 31derived | $7.2M | — | 60.3% | −$2.2M | −$7.5M | — | -0.16 | $1.1M | $196K | $901K | Mar 12 |
| Q3 2023 · Sep 30 | $7M | — | 62.0% | −$1.8M | −$1.4M | — | -0.03 | −$1.2M | $212K | −$1.4M | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $41.1M | 62.3% | −$3M | −$2.6M | -6.4% | -0.06 | $462K | $933K | −$470K | — | — |
| FY2024 · to Dec 31 | $33.6M | 63.4% | −$6.4M | −$6.1M | -18.0% | -0.13 | −$320K | $1.3M | −$1.6M | — | — |
| FY2023 · to Dec 31 | $28.5M | 58.6% | −$10.3M | −$13.7M | -48.2% | -0.30 | −$4.9M | $783K | −$5.7M | — | — |
| FY2022 · to Dec 31 | $27.9M | 55.1% | −$10.8M | −$8.7M | -31.0% | -0.19 | −$5.4M | $2.8M | −$8.2M | — | — |
| FY2021 · to Dec 31 | $23.5M | 58.6% | −$7M | −$4.6M | -19.4% | -0.10 | −$4.3M | $346K | −$4.7M | — | — |
| FY2020 · to Dec 31 | $24.2M | 61.8% | −$1.3M | −$1.2M | -5.0% | -0.03 | −$743K | $921K | −$1.7M | — | — |
Every number comes from KORU Medical Systems, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.